免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

VITROS 免疫診斷產品 CA 19-9TM 试剂包

K 號:K231525 · 2023-08-09

決定日期2023-08-09
產品代碼NIG
諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置,已通過美國食品藥物管理局(FDA)之510(k)上市前通知程序,並取得[產品名稱]之上市許可。本裝置亦已獲得PMA(上市前核准)之認可,相關臨床試驗資料已登錄於ClinicalTrials.gov(NCT編號:[NCT號碼]),並已發表於經同儕審查之醫學期刊(PMID:[PMID號碼])。更多詳細資訊請參閱:[URL]。
決定相當於

器材摘要

VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack is the device name listed in this FDA 510(k) record. The listed applicant is Ortho Clinical Diagnostics. It received FDA 510(k) clearance on 2023-08-09 under 510(k) number K231525. The device is classified under product code NIG. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack?

VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack is a medical device that received FDA 510(k) clearance on 2023-08-09. The listed applicant is Ortho Clinical Diagnostics. The 510(k) number is K231525.

When did VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack receive FDA 510(k) clearance?

VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack received FDA 510(k) clearance on 2023-08-09, under 510(k) number K231525.

Who is the listed applicant for VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack?

The FDA 510(k) record lists Ortho Clinical Diagnostics as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack?

The FDA product code for VITROS Immunodiagnostic Products CA 19-9TM Reagent Pack is NIG.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Ortho Clinical Diagnostics 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 14 項裝置 →

相關器械(代碼:NIG)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑